Diadema Partners »

Amicus Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0M 131k 7.88

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Amicus Therapeutics

Vanguard Group
Wellington Management Company
BlackRock
William Blair Investment Management
venBio Select Advisor
Millennium Management
State Street Corporation
Vestal Point Capital
Citadel Advisors
Point72 Asset Management
Geode Capital Management
Pictet Asset Management Holding SA
Perceptive Advisors
Palo Alto Investors
Soleus Capital Management

View all funds holding Amicus Therapeutics